Q1 2026 · 13F-HR
Tetragon Partners GP Ltdholdings as filed
Filed 2026-05-15 · accession 0000919574-26-003297
$515.1M
Reported value
36
Positions
2026-03-31
Period end
The Brief · Tetragon Partners GP Ltd · Q1 2026
AI · grounded in 13F
Tetragon Partners GP Ltd established a new position in WBD valued at $25.37M. The fund also opened new stakes in DFTX for $3.8M and SLNO for $3.42M. To fund these moves, the firm closed positions in RAPT and AM6, reducing its holdings by $4.46M and $3.71M respectively.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 90364P105 | PATH | UIPATH INC | $279.8M | 54.3% | 25,207,628 | Common | SHARED |
| 50043K406 | KGEI | KOLIBRI GLOBAL ENERGY INC | $37.5M | 7.28% | 6,834,504 | Common | SHARED |
| 934423104 | WBD | WARNER BROS DISCOVERY INC | $25.4M | 4.92% | 923,725 | Common | SHARED |
| 98139A105 | WK | WORKIVA INC | $14.9M | 2.89% | 250,000 | Common | SHARED |
| 55087P104 | LYFT | LYFT INC | $13.3M | 2.58% | 1,000,000 | Common | SHARED |
| 85208T107 | CXM | SPRINKLR INC | $13.2M | 2.56% | 2,200,000 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS LTD | $13.1M | 2.55% | 9,500,000 | Common | SHARED |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $9.9M | 1.92% | 312,316 | Common | SHARED |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $8.0M | 1.55% | 127,198 | Common | SHARED |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $7.4M | 1.44% | 103,037 | Common | SHARED |
| 03589W102 | ANNX | ANNEXON INC | $7.2M | 1.39% | 1,292,455 | Common | SHARED |
| N69605108 | PHVS | PHARVARIS N V | $6.3M | 1.22% | 221,611 | Common | SHARED |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC. | $5.9M | 1.15% | 35,000 | CALL | SHARED |
| G01767105 | ALKS | ALKERMES PLC | $5.7M | 1.10% | 159,791 | Common | SHARED |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $5.6M | 1.08% | 164,839 | Common | SHARED |
| 45258J102 | IMVT | IMMUNOVANT INC | $5.4M | 1.05% | 218,507 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $5.1M | 1.00% | 15,952 | Common | SHARED |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $5.1M | 0.99% | 19,668 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $4.7M | 0.91% | 258,132 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $4.4M | 0.86% | 317,877 | Common | SHARED |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $4.3M | 0.84% | 145,480 | Common | SHARED |
| 24477V105 | DFTX | DEFINIUM THERAPEUTICS INC | $3.8M | 0.73% | 199,994 | Common | SHARED |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $3.4M | 0.66% | 102,125 | Common | SHARED |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC. | $3.4M | 0.66% | 20,059 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $3.3M | 0.65% | 119,340 | Common | SHARED |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $3.3M | 0.64% | 630,161 | Common | SHARED |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $3.2M | 0.62% | 144,620 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $3.1M | 0.61% | 41,764 | Common | SHARED |
| 56565P103 | MPLT | MAPLIGHT THERAPEUTICS INC | $2.3M | 0.44% | 112,115 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $1.8M | 0.35% | 181,543 | Common | SHARED |
| 833445109 | SNOW | SNOWFLAKE INC | $1.5M | 0.29% | 10,000 | Common | SHARED |
| 002942100 | AARD | AARDVARK THERAPEUTICS INC | $1.2M | 0.23% | 316,621 | Common | SHARED |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $1.2M | 0.23% | 37,588 | Common | SHARED |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $826,959 | 0.16% | 39,473 | Common | SHARED |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $295,121 | 0.06% | 52,984 | Common | SHARED |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $278,500 | 0.05% | 50,000 | CALL | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.